Senior Consultant Kim White discussed how to reduce treatment costs in, New Psoriasis Therapies Must Demonstrate Value, as seen in Managed Healthcare Executive.

“Further studies need to be done to demonstrate both the economic and clinical value these products bring to the market—and the rationale for why payers and consumers should pay for them,” she says.

Click here to read Tracey Walker’s full article.